Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group

Archie Bleyer, Mehee Choi, Samuel Wang, Clifton D. Fuller, R. Beverly Raney

Research output: Contribution to journalArticle

11 Scopus citations


Purpose. To assess the rate of spinal cord toxicity in adolescents resulting from chemoradiotherapy of parameningeal sarcoma. Methods and Materials. Of 152 patients with parameningeal sarcoma treated per the Intergroup Rhabdomyosarcoma Study Group protocol from 1977 through 1989, eight developed paralyzing ascending myelitis after intrathecal chemotherapy with cytosine arabinoside, methotrexate, and hydrocortisone administered during and after radiation therapy to volumes that included part of the spinal cord. The eight cases include three not previously published. Results. Of eight patients who developed CNS toxicity after intrathecal chemotherapy and radiotherapy for parameningeal rhabdomyosarcoma, all but one were between 13 and 18 years of age when treated. This severe toxicity occurred in one quarter of 28 adolescents treated with the regimen in comparison with one of 123 children 12 years of age or less (P

Original languageEnglish (US)
Pages (from-to)1205-1210
Number of pages6
JournalPediatric Blood and Cancer
Issue number7
Publication statusPublished - Dec 15 2009



  • Adolescence
  • Intrathecal chemotherapy
  • Radiation myelopathy
  • Sarcoma
  • Spinal cord

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Medicine(all)

Cite this